In this study, we examined the expression of Syndecan-1 and its correlation with the CSC marker CD44, Notch-1 & -3 and EGFR expression in carcinoma tissues of triple negative IBC and non-IBC patients. The gene discussed is SDC1; the disease is inflammatory breast carcinoma.